Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer (Q57693562)
scientific article published on 01 February 2005
Language:
(P31) (Q13442814)
(P50) (Q37375521)
(P304) 1332-3; author reply 1333-4
(P407) (Q1860)
(P433) 6
(P478) 23
(P577) Tuesday, February 1, 2005
(P921) (Q5452194)
(Q420436)
(Q177094)
(Q181257)
(P1433) (Q400292)
(P1476) "Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer" (language: en)
(P2093) Matthias D Hofer
other details
description scientific article published on 01 February 2005

External Links